Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
05/2010
05/19/2010EP2185933A2 Matriptase protein and uses thereof
05/19/2010EP2185710A1 Eukaryotic promoters for gene expression
05/19/2010EP2185706A1 Improved gene silencing methods
05/19/2010EP2185697A1 Thermophilic micro-organisms for ethanol production
05/19/2010EP2185696A1 Cells genetically modified to comprise pancreatic islet glucokinase and uses thereof
05/19/2010EP2185695A2 Differentiation of human embryonic stem cells
05/19/2010EP2185694A2 Neuronal progenitor cells and methods of derivation and purification of neuronal progenitor cells from embryonic stem cells
05/19/2010EP2185693A1 Differentiation of human embryonic stem cells
05/19/2010EP2185691A1 Pluripotent stem cell differentiation by using human feeder cells
05/19/2010EP2185690A2 Propagation of primary cells and use thereof
05/19/2010EP2185688A1 Znf206: a novel regulator of embryonic stem cell self-renewal and pluripotency
05/19/2010EP2185686A1 Dendritic cells
05/19/2010EP2185685A1 Novel methods and cell lines
05/19/2010EP2185684A2 Cell carrier containing collagen
05/19/2010EP1737974B1 Methods for identifying proteins with starch phosphorylating enzymatic activity
05/19/2010EP1292671B9 Method for obtaining characterised muscle-derived cell populations and uses
05/19/2010EP1176970B1 Xenotransplant for cns therapy
05/19/2010EP1015557B1 Plastid promoters for transgene expression in the plastids of higher plants
05/19/2010EP0907735B9 Modulators of tissue regeneration
05/19/2010CN101711280A TEM8 peptides and vaccines comprising the same
05/19/2010CN101711277A Method for constructing mass of myocardial cells and use of the myocardial cell mass
05/19/2010CN101710123A Colloidal gold chromatography test paper for detecting residue of ciprofloxacin and preparation method thereof
05/19/2010CN101709304A Mutational housefly acetylcholinesterase gene and expression vector thereof
05/19/2010CN101709291A Method for in-vitro liver cell differentiation of human marrow mesenchyme stem cells based on VPA inducement
05/19/2010CN101709290A Simple, economic and efficient method for in-vitro maturity of porcine oocytes
05/19/2010CN101709289A Method for inducing transformation of totipotent stem cells into mesenchymal stem cells
05/19/2010CN101709087A Puccinia triticina f.sp.tritic monoclonal antibody and preparation method and application thereof
05/19/2010CN101709084A Optimized serial cytokines and application thereof in inducing pluripotent stem cells
05/19/2010CN101319200B Non-serum medium suitable for microencapsulation CHO cell and uses thereof
05/19/2010CN101238792B Isofemale castor vegetative propagation method
05/19/2010CN101148653B Method for inhibiting brown stain generation of cymbidium plant tissue culture
05/19/2010CN101142897B Radix pseudostell adventitious root inducing and tissue culturing method
05/19/2010CN101120654B Tissue culturing method for chia
05/19/2010CN101116424B Highly effective lily bulblet inducement culture method
05/19/2010CN101088323B Process of in vitro culturing adventitious bud with cotton cotyledon to induce plant regeneration
05/19/2010CN101057557B Non-tube quick reproduction method for seedings of jatropha curcas L.
05/18/2010US7718867 Plants and seeds of hybrid corn variety CH698617
05/18/2010US7718866 Plants and seeds of hybrid corn variety CH350141
05/18/2010US7718865 Plants and seeds of hybrid corn variety CH490055
05/18/2010US7718864 Plants and seeds of hybrid corn variety CH607807
05/18/2010US7718863 Plants and seeds of hybrid corn variety CH465107
05/18/2010US7718862 Plants and seeds of hybrid corn variety CH029910
05/18/2010US7718860 Plants and seeds of corn variety CV911339
05/18/2010US7718858 Nutritionally enhanced inbred maize line HLA18ND
05/18/2010US7718857 Nutritionally enhanced inbred maize line HLA22ND
05/18/2010US7718856 Inbred maize line PHE2E
05/18/2010US7718847 Using vector transformation to generate sperm cells expressing heterologous gene sequences; producing non-human vertebrate that harbours spermatogonial stem cells
05/18/2010US7718846 Animal models of long QT syndrome and uses thereof
05/18/2010US7718789 Compositions and methods for the modification of gene expression
05/18/2010US7718787 Gene families associated with cancers
05/18/2010US7718780 monoclonal antibody specific for human NDRG 2 (N-myc downstream regulated gene 2) protein; used to investigate and treat intractable diseases and cancers using the dendritic cell
05/18/2010US7718779 Prophylactic and therapeutic monoclonal antibodies
05/18/2010US7718778 Antibody reactive with human toll like receptor 3
05/18/2010US7718777 MHC-peptide complex binding ligands
05/18/2010US7718632 RNAi inhibition of alpha-ENaC expression
05/18/2010US7718631 For treating p53 containing cancer
05/18/2010US7718628 modified oligonucleotide for gene therapy; as antitumor agent, anticarcinogenic agent; Inhibiting synthesis and function; arresting cellular proliferation
05/18/2010US7718617 Using tissue preservation solution ( kallikrein inhibitor ) to decrease reperfusion injury of an organ during surgery and/or following removal of organ
05/18/2010US7718429 Transforming bone marrow stromal cells with vector comprising notch receptor, exposing cells to jagged 1 protein, culture and recover myoblast
05/18/2010US7718427 Lymantria xylina cell lines established from pupal tissues of L. xylina Swinhoe; susceptible to insect baculovirus of L. xylina multiple nucleopolyhedrovirus (LyxyMNPV), LdMNPV-like virus, PenuMNPV and microsporidia of Nosema sp. ( from Eurema blanda) and N. bombycis; used to produce biopesticides
05/18/2010US7718426 Preparation method of a hair dermal papilla cell preparation, composition and method for regenerating hair follicles, and animal having regenerated hair follicles
05/18/2010US7718425 Use of a B-cell-depleting antibody for treatment of polyoma virus infections
05/18/2010US7718417 recombinant yeast comprising one or more heterologous nucleic acid molecules encoding an enzyme that converts pyruvate and D-glyceraldehyde 3-phosphate to 1-deoxyxylose 5-phosphate and another that converts 1-deoxy-D-xylulose 5-phosphate to 2-C-methyl-D-erythritol 4-phosphate
05/18/2010US7718401 Expression of HIV polypeptides and production of virus-like particles
05/18/2010US7718400 for increasing insulin sensitivity; decreasing the dose of insulin required for the treatment of diabetes; controlling serum glucose levels; increasing lean tissue mass; increasing overall body strength; and regulating bone resorption
05/18/2010US7718397 Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
05/18/2010US7718391 Assays for identifying modulators of rhomboid polypeptides
05/18/2010US7718383 Human T2R65 taste receptor and related assays for identifying human bitter taste modulators
05/18/2010US7718379 Identifying haematopoietic stem cells based on cell surface markers
05/18/2010US7718376 Identification and isolation of somatic stem cells and uses thereof
05/18/2010US7718196 Rapamycin-resistant T cells and therapeutic uses thereof
05/18/2010US7718173 Anti-pro6094 antibodies
05/18/2010CA2422599C Gibberellin 2-oxidase gene, functions and uses thereof
05/18/2010CA2410413C Fluorescent proteins
05/18/2010CA2407287C Method of forming vertebrate pancreas in vitro
05/18/2010CA2368965C Recombinant il-18 antagonists useful in treatment of il-18 mediated disorders
05/18/2010CA2363965C Protein-induced morphogenesis
05/18/2010CA2323753C Lipopolysaccharide .alpha.-2,3 sialyltransferase of campylobacter jejuni and its uses
05/18/2010CA2302808C 50 human secreted proteins
05/18/2010CA2266429C Hedgehog interacting proteins and uses related thereto
05/18/2010CA2121698C Synthesis of human procollagens and collagens in recombinant dna systems
05/14/2010WO2010054393A1 Methods of inhibiting inflammation-associated tissue damage by inhibiting neutrophil activity
05/14/2010WO2010054221A2 Treatment of chronic inflammatory respiratory disorders
05/14/2010WO2010054187A2 Compositions and methods for regulating sas1r
05/14/2010WO2010054051A1 Erbb-3 (her3)-selective combination therapy
05/14/2010WO2010053987A2 Monoclonal antibody production in b cells and uses therof
05/14/2010WO2010053975A1 Modulation of toll-like receptor 4 expression by antisense oligonucleotides
05/14/2010WO2010053522A2 Methods for identifying and producing neural stem and progenitor cells and their progeny
05/14/2010WO2010053518A2 Methods and compositions for inactivating glutamine synthetase gene expression
05/14/2010WO2010053472A1 Stem cell aggregate suspension compositions and methods for differentiation thereof
05/14/2010WO2010053350A1 Inhibition of viral infection and replication by mesenchymal stem cells (msc) and msc-derived products
05/14/2010WO2010053238A2 Apparatus for realizing three-dimensional neural network
05/14/2010WO2010052904A1 Method for producing neural stem cells
05/14/2010WO2010052715A2 Devices and methods for local treatment of cardiovascular diseases
05/14/2010WO2010052580A2 Hsc self-renewal
05/14/2010WO2010052313A1 Cells, nucleic acid constructs, cells comprising said constructs and methods utilizing said cells in the treatment of diseases
05/14/2010WO2010052229A1 Hla-g polypeptides and pharmaceutical uses thereof
05/14/2010WO2010052228A1 Hla-g proteins and pharmaceutical uses thereof
05/14/2010WO2010052192A1 An isolated multipotent mesenchymal stem cell from human adult glomeruli (hgl-msc), a method of preparing thereof and uses thereof in the regenerative medicine of the kidney
05/14/2010WO2010051639A1 Use of mir-126 for enhancing hematopoietic stem cell engraftment, for isolating hematopoietic stem cells, and for treating and monitoring the treatment of acute myeloid leukemia